Morgan Stanley Haleon PLC Transaction History
Morgan Stanley
- $1.49 Trillion
- Q2 2025
A detailed history of Morgan Stanley transactions in Haleon PLC stock. As of the latest transaction made, Morgan Stanley holds 17,734,937 shares of HLN stock, worth $171 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,734,937
Previous 10,279,456
72.53%
Holding current value
$171 Million
Previous $106 Million
73.87%
% of portfolio
0.01%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding HLN
# of Institutions
705Shares Held
468MCall Options Held
158KPut Options Held
0-
Dodge & Cox San Francisco, CA155MShares$1.5 Billion0.97% of portfolio
-
Clearbridge Investments, LLC New York, NY31.4MShares$303 Million0.28% of portfolio
-
Harding Loevner LP Bridgewater, NJ22.6MShares$217 Million1.62% of portfolio
-
Wellington Management Group LLP Boston, MA16.7MShares$161 Million0.03% of portfolio
-
Bank Of America Corp Charlotte, NC12.4MShares$119 Million0.01% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $44.5B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...